Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Related Posts
The Real Deal on Language Model Optimizers: Performance and Practicality
Training large-scale language models presents significant challenges, primarily due to the increasing computational costs and energy consumption as model sizes…
EasyJet shares soar 10% as budget airline agrees $7.3 billion Castlelake takeover
EasyJet shares surged in early dealmaking Monday after it agreed in principle to takeover bid from Castlelake.
Orchestrate seamless business systems integrations using Amazon Bedrock Agents
Generative AI has revolutionized technology through generating content and solving complex problems. To fully take advantage of this potential, seamless…